ABVX
Abivax S.A.
98.30$
+0.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q2 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +3.5% | -100.0% | – | -100.0% | – | -100.0% | – | -100.0% | – | – | – | |
| – | – | +14.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | +3.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | +116.3% | -49.3% | -19.1% | +49.7% | -9.2% | +0.0% | -1.7% | +43.4% | -19.9% | +11.6% | – | |
| – | – | +137.4% | -35.3% | +15.6% | -29.6% | +6.0% | +2.0% | +0.2% | +206.8% | +1.2% | -71.0% | – | |
| – | – | +134.9% | -51.5% | -20.9% | +42.1% | -6.0% | +0.0% | -1.5% | +73.6% | +147.2% | -71.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -61.2% | -57.5% | +57.9% | +23.7% | -4.2% | +0.0% | -22.4% | +19.7% | +262.5% | -83.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.